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Abstract 
China is a key player in global agricultural markets, and the number one importer of U.S. 
soybeans and cotton, whereby soybeans and cotton are two of the main biotech commodities 
commercialized in the United States.  As of 2005, 87% of soybeans and 79% of cotton planted in 
the U.S. were biotech.  Thus, changes in China’s biotech policies may have a significant impact 
on U.S. biotech commodity exports to China.  An understanding of the evolution of China’s 
biotech regulations and factors that may influence China’s future biotech policies is crucial for 
both U.S. producers and policymakers.  This article introduces the development of China’s 
biotech regulations in detail.  Focusing on soybeans and cotton, the impact of China’s biotech 
policy changes on U.S. trade with China are examined.  Results indicate that changes in China’s 
biotech policies in 2001 did cause delay of U.S. soybean exports to China in the short-run, 
immediately after China’s policies were announced.  However, no long term impacts on U.S. 
soybean exports to China were found.  For cotton, a non-food commodity and China’s dominant 
commercialized biotech commodity, it appears that U.S. cotton exports to China were not 
affected by China’s biotech policies. 
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 China’s Biotech Policies and Their Impacts 
on U.S. Agricultural Exports to China  
Introduction and Objectives 
Agricultural biotechnology has advanced and spread rapidly in both developed and 
developing countries.  Figure 1 shows the global status of biotech commodities by planted 
hectares (James, 2005).  Globally, in 2005 the estimated planted area for biotech varieties 
reached 222 million acres in 11 developing and 10 industrial countries, whereby the U.S. biotech 
commodity planted area equaled 122 million acres, accounting for 55% of the global total 
(James, 2005).  China planted eight million acres of biotech varieties, primarily Bt cotton, 
leading the developing countries and ranking fifth in the world.  In the U.S., the main biotech 
varieties include soybeans, corn, and cotton.  In 2005, 87% of soybeans, 79% of cotton, and 52% 
corn of planted in the U.S. were biotech varieties (USDA-ERS, 2005).  China, a main U.S. 
agricultural trading partner, has also invested heavily in agricultural biotech research, ranking 
second only to the United States.   
Figure 1.  Global Status of Biotech Commodities by Planted Hectares 
 
  1Field tests, environmental releases and commercialization as well as imports and 
consumption of biotech products are regulated in China.  Since China is the number one market 
for U.S biotech soybeans and cotton, any Chinese biotech policy changes are expected to have a 
significant impact on U.S. agricultural biotech exports to China.  In this research, the objectives 
are 1) to explore U.S. agricultural biotech commodity production and exports to China, 2) to 
provide an overview of China’s biotech policies, 3) to assess the impact of China’s biotech 
policies on U.S. biotech exports to China, and 4) to identify factors affecting China’s biotech 
policies.  
Outlook of U.S. Agricultural Biotech Exports to China 
The U.S. leads the world in agricultural biotech research, adoption, commercialization, 
and exports.  The main U.S. biotech commodities include soybeans, corn, and cotton.  Table 1 
shows their growth in planted acreage, which has dramatically increased in recent years (USDA-
ERS, 2005).  The share of planted acreage for biotech soybeans increased 33% from 2000 to 
2005, cotton 18%, and corn 27%.  In addition, soybeans, corn, and cotton are among the top U.S. 
agricultural exports for bulk commodities (USDA-FAS, 2006).  In 2005, the export value for U.S. 
soybeans totaled 8 billion dollars; corn less than 6 billion dollars; and cotton more than 4 billion 
dollars
*.  The export value for these three commodities accounted for 28% of total U.S. 
agricultural exports in 2005 (soybeans 13%, corn 9%, and cotton 6%).  As such, these U.S. 
biotech commodities depend highly on international markets.  In 2005, U.S. soybean exports 
accounted for 33% of total domestic production, corn 16%, and cotton 57% (USDA-FAS, 2006). 
 
                                                 
*This soybean export value includes soybeans, soybean oil, and soybean cake and meal. The corn export value includes corn, 
corn oil, corn oilcake and meal, and corn gluten feed and meal.  The cotton export value includes cotton, cotton linters, 
cottonseed, cottonseed cake and meal, and cottonseed oil.  
  2Table 1.  Main U.S. Biotech commodities (Percent of Planted Acreage) 
Commodity 2000  2001  2002  2003 2004  2005 
Soybeans 54%  68%  75% 81% 85%  87% 
Cotton 61  69  71  73  76  79 
Corn 25  26  34  40  45  52 
Source: USDA-ERS, 2005. 
  From a marketing perspective, China is one of the most important U.S. agricultural 
export markets (figure 2), especially for U.S. biotech soybeans and cotton (table 2). Table 2 
indicates that China was the number one importer for both U.S. soybeans (53%) and cotton 
(32%) in 2004.  China’s soybean imports from the U.S. skyrocketed in the last decade while 
China’s cotton imports from the U.S. increased only in recent years.  Additionally, the U.S. is a 
main soybean and cotton supplier for China.  Table 3 shows that U.S. soybean exports to China 
accounted for 42% of China’s total soybean imports in 2004, and U.S. cotton exports to China 
accounted for 44% of China’s total cotton imports.  
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Table 2.  Top Markets for Leading U.S. Agricultural Biotech Commodities in 2005 
Commodities  Main Exports Markets  Market Share 
(Percentage of U.S. Total Exports) 
China  37% 
The EU (25)  10% 
Mexico  13% 
Japan  11% 
Soybeans 
Sum  71% 
Japan  33% 
Mexico  13% 
Canada  5% 
Egypt  8% 
Corn 
Sum  58% 
China  36% 
Turkey  14% 
Mexico  10% 
Cotton 
Sum  60% 
Source: USDA-FAS, 2006. 
 
 
Table 3.  China's Imports of Soybeans and Cotton 
Commodity Imports and Share  1996 1997 1998 1999 2000 2001  2002  2003 2004
China's Total Imports 
(Million MTs) *  3.80 5.63 5.19 6.67 12.72 16.38 13.85 23.19 22.26
China's Imports from the 
U.S.  (Million MTs) ** 1.49 1.52 1.24 1.88 5.23 5.44 4.86  11.11 9.40 Soybeans 
U.S. Share of China's  
Market (%)  39% 27% 24% 28% 41% 33% 35% 48% 42%
 
China's Total Imports 
(Million MTs) *  1.29 1.10 1.16 0.66 0.46 0.54 0.47 0.61 1.34
China's Imports from the
U.S. (Million MTs) ** 0.49 0.42 0.37 0.10 0.04 0.06 0.05 0.17 0.58 Cotton 
U.S. Share of China's  
Market (%)  38% 38% 32% 14% 8% 12% 11% 27% 44%
* Data from FAO, 2006.  **Data from USDA-FAS, 2006. 
 
  4Agricultural Biotech Research and Development in China  
With only about 7% of the world's arable land feeding over 20% of the world's 
population, China is challenged by its great demand for food.  Development of agricultural 
biotechnology has become an important tool to achieve China’s food security.  China, one of the 
world's largest producers of agricultural commodities, produced 31% of world rice, 27% of 
rapeseed, 27% of cotton, 19% of corn, 16% of wheat, and 9% of soybeans in 2004 (FAO, 2005).  
China is also a large player in international agricultural markets, exporting 4 million metric tons 
of corn and importing 22 million metric tons of soybeans in 2004 (USDA-FAS, 2006).   
China’s biotechnology development began in the mid-1980s (Huang, et al., 2002; 
Marchant and Tuan, 2002).  Agricultural biotechnology has been strongly supported by the 
Chinese government.  More than 100 laboratories were established to integrate biotechnology 
into conventional Chinese agriculture (Huang, et al., 2002).  By the year 2001, more than 130 
biotech varieties with more than 100 different traits including insect-resistance, bacterial-, 
fungus- and virus-resistance, salt-tolerance, drought-resistance, nutrition enrichment, quality 
improvement, production of edible oral vaccines and recombinant pharmaceuticals, were 
obtained (Chen and Qu, 2003).  
Since 1997, after safety evaluation, the Chinese Minister of Agriculture (MOA) has 
approved the release of 10 biotech varieties including biotech rice, corn, cotton, soybeans, 
rapeseeds, and potato.  Among these biotech varieties, Bt cotton, delayed ripening tomatoes, 
cucumber mosaic virus (CMV)-resistant sweet peppers, and color-altered petunias have been 
commercialized (Lu and Zhou, 2004).  By far, Bt cotton is the dominant biotech commodity in 
China.  China’s acreage planted with Bt cotton increased by 32% from 2.8 million hectares in 
  52003 to 3.7 million hectares, which accounted for 66% China’s total cotton planted area in 2004 
(James, 2004). 
Agricultural Biotech Policies in China 
Field tests, environmental releases and commercialization of biotech plants are regulated 
in China as shown in figure 3 (Marchant and Song, 2005).  In November 1993, the State Science 
and Technology Commission of China issued its “Biosafety Administration Regulations on 
Genetic Engineering”, which was China’s first law on biosafety (Marchant, Fang, and Song, 
2002).  Three years later, “Biosafety Administration Implementation Regulations on Agricultural 
Genetic Engineering” was issued by the Ministry of Agriculture (MOA) of China, and took 
effect on the same date, July 10, 1996 (Chinese MOA, 1996).  
Prior to China’s accession into the World Trade Organization on December 11, 2001, the 
Chinese government passed its “Biosafety Administration Regulations on Agricultural Biotech 
Products,” which were issued and took effect on May 23, 2001 (Chinese MOA, 2001a).  These 
regulations provided general guidelines for the development, distribution, and use of agricultural 
biotech products.  These regulations required a safety certificate and labeling for any agricultural 
biotech products from either domestic sources or imports.  The Chinese MOA issued three 
separate implementing regulations for the above guidelines on January 5, 2002:  (1) “Biosafety 
Evaluation and Administration Regulations on Agricultural Biotech Products,” (2) “Import 
Safety Administration Regulations on Agricultural Biotech Products,” and (3) “Labeling 
Administration Regulations on Agricultural Biotech Products” (Chinese MOA, 2001b).  These 
new regulations placed restrictions on Chinese imports of biotech products, including those 
imported from the United States.  The effective date for implementation was originally set for 
March 20, 2002.  
  6 
Figure 3.  History of China’s Biotech Regulations 
“Biosafety Administration Regulations on Genetic Engineering” was 
issued by the State Science and Technology Commission and took effect 
on the same date, December 24, 1993.  
July 1996 
December 1993 
“Biosafety Administration Implementation Regulations on 
Agricultural Genetic Engineering” was issued by the Ministry of 
Agriculture of China, and took effect on the same date, July 10, 1996.  
May 2001 
“Biosafety Administration Regulations on Agricultural Transgenic 
Products” were passed by the State Council of China on May 9, 2001, 
and issued and took effect on May 23, 2001.  
July 2001 
(1)“Biosafety Evaluation and Administration Regulations on 
Agricultural Transgenic Products,” (2)“Labeling Administration 
Regulations on Agricultural Transgenic Products,” and (3)“Import 
Safety Administration Regulations on Agricultural Transgenic 
Products” were passed by the Chinese Ministry of Agriculture on July 
11, 2001, with an effective date for implementation on March 20, 2002. 
March 2002 
“Temporary Administration Procedure of Import of Agricultural 
biotech Products” was issued on March 10, 2002 before the above 
effective date March 20, 2002, and scheduled to terminate on December 
20, 2002.  
October 2002 
On October 11, 2002, the Chinese Ministry of Agriculture announced that 
the above temporary import regulations would be extended to September 
20, 2003.  
On April 8, 2002, the Chinese Ministry of Health issued “the Sanitary 




On July 17, 2003, the Chinese Ministry of Agriculture announced that the 
above temporary import regulations would be further extended to April 
20, 2004. 
April 2004 
“The Administrative Measures of Inspection and Quarantine on 
Entry-Exit Transgenic Products” was issued on May 24, 2004 by 
China's State General Administration for Quality Supervision, Inspection 
and Quarantine (AQSIQ) and took effect on the same day.  
May 2004 
The temporary import regulations expired and the above three regulations 









































  7Specific rules on imports of biotech products from the above regulations included the 
following:  (1) biotech products imported into China required test results or data obtained from 
in-country field experiments within the exporting country (or a third country) to prove products 
are safe for human consumption and do not impose biosafety risks to other plants, animals, or the 
environment,  (2) each shipment of biotech products imported into China needs a single or 
separate safety certificate accompanying each shipment, (3) the Chinese Ministry of 
Agriculture’s approval process can take up to 270 days to grant safety certificates required for 
imported biotech products, (4) there is a "zero" threshold level (based on qualitative test results) 
for biotech content in foods, and (5) decision-making should be based on demonstrated risks 
(bioharzards) from scientific data, whereby the expert panel should play an important role in the 
decision-making process. 
Rules on labeling of biotech products included the following:  (1) all products containing 
biotech content should be labeled correctly, otherwise, products are not allowed to enter unless 
re-labeled, (2) labeling rules are applied to the following imported biotech products:  soybean 
seeds, soybeans, soybean flour, soymeal, soyoil, corn seeds, corn, corn oil, corn meal, rapeseed 
seeds, rapeseeds, rapeseed oil, rapeseed meal, cotton seeds, tomato seeds, fresh tomatoes, and 
tomato ketchup (tomato jam). 
Before the effective date to implement these three regulations (March 20, 2002), the 
Chinese government delayed their implementation (Chinese MOA, 2003).  Instead, the Chinese 
MOA issued a temporary measure, “Temporary Administration Procedure of Import of 
Agricultural Biotech Products”, which allowed exporters to ship biotech products, including 
U.S. biotech soybeans, into China using temporary import certificates through December 20, 
2002.  Each temporary import certificate granted by the Chinese MOA was good for 10 
  8shipments (Chinese MOA, 2002).  After three extensions of this temporary measure, the above 
three regulations eventually took effect on April 20, 2004 (USDA-FAS, 2004).  
Immediately after the effective date of implantation for these three regulations, China's 
State General Administration for Quality Supervision, Inspection and Quarantine (AQSIQ) 
announced a new regulation related to the administration of biotech products, “Administrative 
Measures of Inspection and Quarantine on Entry-Exit of Biotech Products”, on May 24, 2004 
(Chinese AQSIQ, 2004; USDA-FAS, 2004).  These measures not only apply to the inspection 
and quarantine of biotech products via trade, but also apply to processing, research, and 
production.  By these new measures, Chinese importers must declare whether the imported 
products are biotech or not when they apply for inspection and quarantine.  If the products are 
biotech, the importers shall provide relevant documents including a safety certificate and review 
and approval documents needed for labeling.  For biotech products, labeling is mandatory by the 
above implementing regulations.  In addition, these measures also authorize the AQSIQ to 
conduct random biotech tests even if products are declared as non-biotech.  
Impacts of China’s Biotech Policies on U.S. Exports to China 
China’s biotech regulations and policies did raise concern by U.S. agricultural exporters 
and policymakers as well as Chinese agricultural importers.  Requiring safety certificates 
incurred additional costs and shipment delays at the initiation of these new regulations in late 
spring and summer 2001.  In addition, these regulations have the potential to be used by the 
Chinese government as a non-tariff barrier to control soybean imports.  
Soybeans 
Figure 6 compares U.S. soybean exports to China between 2000 and 2001, pre- and post- 
announcement of these import regulations.  After the Chinese government announced the three 
  9biotech implementing regulations, U.S. soybean exports to China fell, especially from May to 
September in 2001, whereby U.S. soybean exports to China temporarily ceased.  Additionally, 
U.S. soybean exports to China were also affected by seasonal factors, whereby China typically 
increases soybean imports from Brazil and Argentina during this period.  However, China’s 
soybean imports from the U.S. were zero from May to September in 2001, compared to average 
monthly imports of 302,000 metric tons from May to September in 2000.  Besides these seasonal 
factors, China’s biotech policies may have played an additional role in the cessation of China’s 
soybean imports from the United States in the summer of 2001. Figures 4 implies that China’s 
biotech regulations caused U.S. soybean exports to China to temporarily fall in the short term.  
However, looking back at China's soybean imports from the U.S. in table 3, it appears that these 
biotech regulations did not impose significant impacts on U.S. soybean exports to China in the 
long-run.  
Figure 4.  U.S. Monthly Soybean Exports to China in 2000 and 2001 


















Source: USDA-FAS, 2006. 
 
  10Cotton 
For biotech cotton, the impact of China’s biotech policies on U.S. exports differed from 
that of soybeans.  Since cotton is not a food product, food safety issues do not apply.  In addition, 
cotton is the main biotech commodity commercialized for sale in China.  Figure 5 shows that 
after China announced its three implementing biotech regulations in 2001, U.S. cotton exports to 
China did not dramatically change.  Thus, the announcement of China’s biotech regulations does 
not appear to have had a significant impact on U.S. cotton exports to China.  Figure 6 indicates 
that U.S. cotton exports to China dramatically increased in recent years, regardless of China’s 
biotech policies.  
Figure 5.  U.S. Monthly Cotton Exports to China in 2000 and 2001 


















Source:  USDA-FAS, 2006. 
Additional Factors 
To enhance U.S. exports, USDA-FAS provides a series of technical assistance, education, 
and outreach programs for developing countries, including China.  For example, these programs 
give Chinese officials, policymakers, and researchers a better understanding of agricultural 
biotechnology in the United States (USDA-FAS, 2003).  Upon China’s announcement of its 
  11import regulations in 2001, U.S. trade delegations negotiated with the Chinese government.  
These negotiations along with USDA’s educational programs, and mutual visits played an 
important role in removing obstacles for U.S exports of agricultural biotech products to China.   
Figure 6.  U.S. Cotton Exports to China from 1999 to 2005 
U.S. Cotton Exports to China


















U.S. Cotton Exports to China
 
Source: USDA-FAS, 2006. 
Another key factor affecting China’s biotech policies is China’s domestic soybean 
shortage.  Figure 7 shows that after 1997, China’s domestic soybean demand increased 
dramatically, while domestic production increased slowly, creating a significant soybean 
shortage in China.  In 2005, the soybean shortage (domestic consumption minus production) 






































Source:  USDA-FAS, 2006.  
Figure 8.  China’s Soybean Production Area and Crushing Facilities 
 
  From a domestic production viewpoint, China’s soybeans are produced mainly in the 
Northeast region (figure 8).  In contrast, large crushing facilities to process soybeans into soyoil 
and soymeal have been recently built along coastal provinces.  Most of these crushing facilities 
are supplied by imported soybeans.  About 45% of domestic soybeans are used directly for food, 
and the remainder is not enough to supply expanded crushing capacities.  With the rapid growth 
  13of both Chinese consumers’ income and livestock industry, China’s increased demand for soyoil, 
used for cooking, and soymeal, used for feed, also significantly contributes to China’s large 
soybean shortage.  If the Chinese government chooses to control soybean imports through 
biotech policies, it might dramatically increase China’s domestic soybean prices, which could 
eventually hurt Chinese crushers and consumers. Other factors, including food safety and 
environment safety considerations, protection of China’s domestic producers, crushers and 
consumers, WTO commitments, and political reasons also play important roles in China’s 
attitude towards biotech products (Zhong, et al., 2002).  
Summary and Conclusions 
China is one of the world's large producers, importers, and consumers of major 
agricultural commodities and has been a critical player in the international food market.  In 
addition, China is the leading importer of both soybeans and cotton — globally and for the 
United States. Soybeans and cotton are among the top biotech varieties commercialized in the 
United States.  The significance of soybean and cotton trade between the U.S. and China and the 
announcement of China’s recent biotech regulations attracted attention from both sides, since 
85% of U.S. soybean production and 76% of cotton production are biotech varieties, and China 
is our top export market for both commodities.   
  China’s biotech development began in the mid-1980s and has become one of a few large 
countries involved in biotech research throughout the world.  China’s general “Biosafety 
Administration Regulations on Agricultural Transgenic Products” issued on May 23, 2001, and 
subsequent implementing regulations issued on January 5, 2002, had the potential to disrupt 
imports of U.S. biotech products into China, particularly biotech soybeans—a main food and 
feed product.  Through USDA educational and exchange programs along with trade negotiations, 
  14the Chinese government delayed implementing these regulations three times, which ultimately 
took effect on April 21, 2004.  Between 2001 and 2004, the Chinese Ministry of Agriculture 
issued temporary import regulations allowing biotech imports into China, including U.S. biotech 
soybeans.  
  When examining the impacts of these biotech policies on U.S. agricultural exports to 
China, U.S. soybean export delays did occur immediately after the announcement of these three 
regulations in April 2001.  However, in the long-run, China’s biotech policies did not appear to 
impose a significant impact on U.S. soybean exports to China.  Since cotton is not used for food 
consumption, food safety concerns do not apply.  In addition, Bt cotton is currently the dominant 
commercialized biotech commodity in China.  Viewing the data on U.S. exports of biotech 
cotton to China upon announcement of China’s biotech regulations, it appears that China’s 
biotech policies did not have an impact on U.S. cotton exports.  In regards to China’s future 
biotech policies, several important factors will impact the change of China’s biotech regulations:  
food and environment safety concerns, WTO commitments, and political pressure from foreign 
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